BioMarin Pharmaceutical Inc. (BMV:BMRN)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 19, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	211,538	261,031	307,053	375,171	332,528	316,749
Market Cap Growth	-30.39%	-14.99%	-18.16%	12.82%	4.98%	10.58%
Enterprise Value	196,067	254,201	306,536	371,611	332,698	316,732
Last Close Price	1077.32	1700.00	1375.00	2132.23	1845.00	1734.00
PE Ratio	17.07	29.35	108.34	135.87	-	18.64
PS Ratio	3.66	4.39	7.51	9.18	8.79	8.56
PB Ratio	1.86	2.21	3.67	4.18	3.80	3.88
P/TBV Ratio	2.01	2.44	4.10	4.73	4.41	4.56
P/FCF Ratio	16.14	25.70	290.28	350.06	77.63	-
P/OCF Ratio	14.63	21.87	114.04	109.34	53.26	186.47
EV/Sales Ratio	3.43	4.28	7.50	9.09	8.79	8.56
EV/EBITDA Ratio	10.83	18.30	62.49	121.62	481.22	1186.81
EV/EBIT Ratio	12.04	21.40	97.60	348.42	-	-
EV/FCF Ratio	14.96	25.03	289.80	346.74	77.67	-
Debt / Equity Ratio	0.10	0.11	0.23	0.24	0.26	0.28
Debt / EBITDA Ratio	0.62	0.93	3.73	6.58	23.56	43.10
Debt / FCF Ratio	0.87	1.30	18.12	20.38	5.38	-
Asset Turnover	0.42	0.41	0.37	0.34	0.31	0.35
Inventory Turnover	0.44	0.50	0.53	0.60	1.49	1.67
Quick Ratio	3.34	2.96	1.45	2.98	2.54	3.07
Current Ratio	5.56	5.33	2.51	4.67	4.16	4.76
Return on Equity (ROE)	11.62%	8.05%	3.51%	3.19%	-1.53%	23.63%
Return on Assets (ROA)	7.50%	5.15%	1.76%	0.55%	-0.78%	-1.09%
Return on Capital (ROIC)	8.37%	5.76%	1.97%	0.61%	-0.87%	-1.24%
Return on Capital Employed (ROCE)	12.90%	8.90%	3.30%	0.90%	-	-
Earnings Yield	5.86%	3.41%	0.92%	0.74%	-0.40%	5.37%
FCF Yield	6.20%	3.89%	0.34%	0.29%	1.29%	-0.18%
Buyback Yield / Dilution	-0.35%	-2.67%	-1.39%	-3.34%	4.61%	-7.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.